↓ Skip to main content

Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies

Overview of attention for article published in Frontiers in oncology, January 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
12 X users
patent
3 patents

Citations

dimensions_citation
196 Dimensions

Readers on

mendeley
209 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
Published in
Frontiers in oncology, January 2020
DOI 10.3389/fonc.2019.01380
Pubmed ID
Authors

Mark P. Chao, Chris H. Takimoto, Dong Dong Feng, Kelly McKenna, Phung Gip, Jie Liu, Jens-Peter Volkmer, Irving L. Weissman, Ravindra Majeti

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 209 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 209 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 34 16%
Student > Ph. D. Student 20 10%
Student > Master 17 8%
Student > Bachelor 16 8%
Student > Doctoral Student 12 6%
Other 29 14%
Unknown 81 39%
Readers by discipline Count As %
Medicine and Dentistry 37 18%
Immunology and Microbiology 25 12%
Biochemistry, Genetics and Molecular Biology 20 10%
Agricultural and Biological Sciences 14 7%
Engineering 5 2%
Other 24 11%
Unknown 84 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 December 2023.
All research outputs
#1,364,107
of 25,387,668 outputs
Outputs from Frontiers in oncology
#230
of 22,433 outputs
Outputs of similar age
#33,653
of 473,132 outputs
Outputs of similar age from Frontiers in oncology
#6
of 430 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,433 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 473,132 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 430 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.